The content of matrix metalloproteinase-1,-9 and tissue inhibitor of matrix metalloproteinase-1 in patients with bronchial asthma and obesity

被引:0
|
作者
Kachkovska, V. V. [1 ]
Prystupa, L. N. [2 ]
机构
[1] Sumy State Univ, Ctr Resp Med, Dept Internal Med, UA-40007 Sumy, Ukraine
[2] Sumy State Univ, Ctr Resp Med, Internal Med, Sumy, Ukraine
来源
PATHOLOGIA | 2023年 / 20卷 / 03期
关键词
asthma; obesity; matrix metalloproteinase-1; matrix metalloproteinase-9; tissue inhibitor of metalloproteinase-1; course; control;
D O I
10.14739/2310-1237.2023.3.291212
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Airway remodeling is a significant factor in the progression of respiratory failure in bronchial asthma (BA). Obesity can contribute to inflammation, and consequently - airway remodeling, by increased production of matrix proteinase (MMP). However, the mechanisms of remodeling in different phenotypes of BA, especially in comorbid patients, remain poorly understood.The aim of the research was to examine the levels of remodeling markers MMP-1, MMP-9 and tissue inhibitor of matrix proteinases (TIMP-1) in obese asthmatic patients, taking into account their age at the onset of BA, the severity of symptoms and the level of control. Material and methods. 195 patients with BA associated with obesity were examined. The control group consisted of 95 practically healthy people. Patients were divided into two groups: Group I included 100 patients with early onset, and Group II included 95 patients with late onset of BA. The study was approved by the Bioethics Commission of the Medical Institute of Sumy State University. Statistical analysis of the obtained results was carried out using the SPSS-17 program.Results. The content of MMP-1,-9 and TIMP-1 was higher in patients with early (129.40 +/- 7.86; 177.30 +/- 9.19; 142.40 +/- 12.22 ng/ml, respectively) and late (196.60 +/- 9.62; 289.80 +/- 16.23; 187.50 +/- 11.34 ng/ml, respectively) BA with obesity compared to practically healthy individuals (p < 0.005). Patients with late-onset BA associated with obesity likely had higher indicators than those with early BA. In patients with early BA, the levels of MMP-1,-9, and TIMP-1 were not significantly different depending on the severity of the disease (p > 0.05). However, in patients with severe late BA, the levels of these markers were higher compared to those with mild BA (p < 0.05). Levels of MMP-1 and MMP-9 in patients with early-onset and late-onset BA with obesity were higher in the absence of disease control compared to those in complete and partial control, but in late-onset exceeded those in early-onset.Conclusions. Considering the obtained results, it can be assumed that the level of MMP-1, MMP-9 and TIMP-1 in obese patients with BA can serve as biomarkers of airway remodeling, namely, the severity and the level of BA control.
引用
收藏
页码:238 / 242
页数:5
相关论文
共 50 条
  • [41] Crystal structure of the catalytic domain of matrix metalloproteinase-1 in complex with the inhibitory domain of tissue inhibitor of metalloproteinase-1
    Iyer, Shalini
    Wei, Shuo
    Brew, Keith
    Acharya, K. Ravi
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (01) : 364 - 371
  • [42] Influence of hypoxia on the expression of matrix metalloproteinase-1,-3 and tissue inhibitor of metalloproteinase-1 in rheumatoid synovial fibroblasts
    Cha, HS
    Ahn, KS
    Jeon, CH
    Kim, J
    Song, YW
    Koh, EM
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2003, 21 (05) : 593 - 598
  • [43] Patients with acute coronary syndromes have increased levels of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1
    Manginas, A
    Bel, E
    Pilatis, N
    Chaidaroglou, A
    Degiannis, D
    Koniavitou, E
    Gokkinos, DV
    [J]. CIRCULATION, 2002, 106 (19) : 695 - 695
  • [44] Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF
    Henry, MT
    McMahon, K
    Mackarel, AJ
    Prikk, K
    Sorsa, T
    Maisi, P
    Sepper, R
    FitzGerald, MX
    O'Connor, CM
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2002, 20 (05) : 1220 - 1227
  • [45] Serum matrix metalloproteinase-9/tissue inhibitor of matrix metalloproteinase-1 and left venricle performance in patients with aortic stenosis
    Goncharova, N.
    Moiseeva, O.
    Aleshina, G.
    Shlykhto, E.
    [J]. CIRCULATION, 2008, 118 (12) : E248 - E248
  • [46] Imbalance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in toluene diisocyanate-induced asthma
    Lee, KS
    Jin, SM
    Lee, H
    Lee, YC
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2004, 34 (02): : 276 - 284
  • [47] Imbalance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in toluene diisocyanate-induced asthma
    Choi, E
    Lee, YC
    [J]. CHEST, 2003, 124 (04) : 139S - 140S
  • [48] The Balance of Tissue Inhibitor of Metalloproteinase-1 and Matrix Metalloproteinase-9 in the Autoimmune Inner Ear Disease Patients
    Eisner, Logan
    Vambutas, Andrea
    Pathak, Shresh
    [J]. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2017, 37 (08): : 354 - 361
  • [49] Serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in patients with familial Mediterranean fever
    Dinc, Mustafa
    Tanoglu, Alpaslan
    Yazgan, Yusuf
    Beyazit, Yavuz
    Oncu, Kemal
    Onem, Yalcin
    Hira, Serdar
    Kaplan, Mustafa
    Kucuk, Irfan
    Sakin, Yusuf Serdar
    Demirturk, Levent
    [J]. TURKISH JOURNAL OF GASTROENTEROLOGY, 2015, 26 (06): : 487 - 491
  • [50] SIGNIFICANCE OF SERUM MATRIX METALLOPROTEINASE-9 AND TISSUE INHIBITOR OF METALLOPROTEINASE-1 IN CHRONIC HEPATITIS C PATIENTS
    Badra, Gamal
    Lotfy, Mahmoud
    El-Refaie, Amany
    Obada, Moanis
    Abdelmonem, Elhamy
    Kandeel, Samia
    Fathy, Amr
    [J]. ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA, 2010, 57 (01) : 29 - 42